Anti-BICRA antibodies are used in the immunodetection of the protein BRD4 interacting chromatin remodeling complex associated protein. In humans, the canonical protein has a reported length of 1560 amino acid residues and a mass of 158.5 kDa. Its subcellular localization is in the nucleus. Up to 2 different isoforms have been reported for this protein. It is noted to be expressed at moderate levels in the heart, brain, placenta, skeletal muscle, and pancreas, and at lower levels in the lung, liver and kidney. BICRA is known to be a component of SWI/SNF chromatin remodeling subcomplex GBAF that carries out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Synonyms for this target antigen include GLTSCR1, SMARCK1, BRD4 interacting chromatin remodelling complex associated protein, glioma tumor suppressor candidate region gene 1 protein, and CSS12. A number of BICRA antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. ELISA and Immunohistochemistry are also common applications.